BioImagene (Cupertino, CA) commercial-stage provider of digital pathology solutions for cancer diagnosis and preclinical research, closed a $26M Series D financing. Participants include Burrill & Co., Ascension Health Ventures, National Healthcare Services, Artiman Ventures and ICCP Ventures.